Advertisement
Advertisement

PCVX

PCVX logo

Vaxcyte Inc

85.74
USD
-4.12
-4.58%
Dec 18, 15:59 UTC -5
Closed
...

Vaxcyte Inc Profile

About

Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.

Info & Links

CEO

Grant E. Pickering

Headquarters

825 INDUSTRIAL ROAD, SUITE 300
SAN CARLOS, CA 94070, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

254

Vaxcyte Inc Statistics

Valuation Measures

Market Capitalization2

10.69B

Enterprise Value

9.64B

Enterprise Value/EBITDA(ttm)

-15.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.86

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-23.53%

Return on Invested Capital(ttm)

-28.86%

Return on Assets(ttm)

-22.20%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-619.44M

Net Income Available to Common(ttm)

-507.65M

Diluted EPS(ttm)

-4.60

Share Statistics

Beta (5Y Monthly)

0.94

52-Week Change

58.25%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

124.64M

Dividend Yield

0.00%

Float4

120.77M

% Held by Insiders

3.10%

% Held by Institutions

96.78%

Balance Sheet

Total Cash(mrq)

2.18B

Total Cash Per Share(mrq)

17.49

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.88%

Quick Ratio(mrq)

17.88%

Book Value Per Share(mrq)

27.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.76

Free Cash Flow(ytd)

-359.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement